Anis NA, Berry SC, Burton NR, Lodge D (1983): The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N–methyl–aspartate. Br J Pharmacol79:565–575 ArticleCASPubMedPubMed Central Google Scholar
Ban TA, Lohrenz JJ, Lehmann HE (1961): Observations on the action of sernyl—a new psychotropic drug. Can J Psychiatry6:150–157 CAS Google Scholar
Byrd LD, Standish LJ, Howell LL (1987): Behavioral effects of phencyclidine and ketamine alone and in combination with other drugs. Eur J Pharmacol144:331–341 ArticleCASPubMed Google Scholar
Cohen BD, Rosenbaum G, Luby ED, Gottlieb JS (1962): Comparison of phenylcyclidine hydrochloride (Sernyl) with other drugs. Arch Gen Psychiatry6:395–397 ArticleCASPubMed Google Scholar
Cohen ML, Chan SL, Bhargava HN, Trevor AJ (1974): Inhibition of mammalian brain acetylcholinesterase by ketamine. Biochem Pharmacol23:1647–1652 ArticleCASPubMed Google Scholar
Crosby G, Crane AM, Sokoloff L (1982): Local changes in cerebral glucose utilization during ketamine anesthesia. Anesthesiologist56:437–443 ArticleCAS Google Scholar
Davies BM, Beech HR (1960): The effect of 1-arylcyclohexylamine (Sernyl) on twelve normal volunteers. J Ment Sci106:912–924 ArticleCASPubMed Google Scholar
Hammer RP, Herkenham M (1983): Altered metabolic activity in the cerebral cortex of rats exposed to ketamine. J Comp Neurol220:396–404 ArticleCASPubMed Google Scholar
Javitt DC, Zukin SR (1991): Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry148:1301–1308 ArticleCAS Google Scholar
Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers Jr MB, Charney DS (1994): Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry51:199–214 ArticleCAS Google Scholar
Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995): Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology13:9–19 ArticleCAS Google Scholar
Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R (1959): Study of a new schizophrenomimetic drug-sernyl. Arch Neurol Psychiatry81:363–369 ArticleCAS Google Scholar
Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D, Breier A (1996): NMDA receptor function and human cognition: The effects of ketamine in healthy volunteers. Neuropsychopharmacology14:301–307 ArticleCAS Google Scholar
Moretti RJ, Hassan SZ, Goodman LI, Meltzer HY (1984): Comparison of ketamine and thiopental in healthy volunteers: Effects on mental status, mood, and personality. Anesth Analg63:1087–1096 ArticleCASPubMed Google Scholar
Olney JW, Labruyere J, Price MT (1989): Pathological changes induced in cerebrocortical neurons by phenylcyclidine and related drugs. Science244:1360–1362 ArticleCASPubMed Google Scholar
Olney JW, Farber NB (1995): Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry52:998–1007 ArticleCASPubMed Google Scholar
Overall JE, Gorham DR (1962): The brief psychiatric rating scale. Psychol Rep10:799–812 Article Google Scholar
Oye I, Hustveit O, Moberg ER, Pausen O, Skoglund LA (1991): The chiral forms of ketamine as probes for NMDA receptor function in humans. In Kameyama T, Nabeshima T, Domino EF (eds), NMDA Receptor Related Agents: Biochemistry, Pharmacology, and Behavior. Ann Arbor, Michigan, NPP Books, pp 381–389 Google Scholar
Pandit SK, Kothary SP, Kumar SM (1980): Low dose intravenous infusion technique with ketamine. Anaesthesia35:669–675 ArticleCASPubMed Google Scholar
Rosenbaum G, Cohen BD, Luby ED, Gottlieb JS, Yelen D (1959): Comparison of Sernyl with other drugs. A. M. A. Arch Gen Psychiatry1:651–666 ArticleCAS Google Scholar
Rothman S (1988): Noncompetitive N-methyl-D-aspartate antagonists affect multiple ionic currents. J Pharmacol Exp Ther246:137–142 CASPubMed Google Scholar
Schorn TOF, Whitman JG (1980): Are there long-term effects of ketamine on the central nervous system? Br J Anaesth52:967–968 ArticleCASPubMed Google Scholar
Smith DJ, Azzaro AJ, Zaldivar SB, Palmer S, Lee HS (1981): Properties of the optical isomers and metabolites of ketamine on the high affinity transport and catabolism of monoamines. Neuropharmacology20:391–396 ArticleCASPubMed Google Scholar
Smith DJ, Pekoe GM, Martin LL, Coalgate B (1980): The interaction of ketamine with the opiate receptor. Life Sci26:789–795 ArticleCASPubMed Google Scholar
Spitzer RL, Williams JBW, Gibbon M, First MB (1990): Structured clinical interview for DSM–III–R–patient edition (SCID-P, Version 1.0). Washington, DC: American Psychiatric Press
Weingartner HJ, Hommer D, Lister RG, Thompsom K, Wolkowitz O (1992): Selective effects of triazolam on memory. Psychopharmacology106:341–345 ArticleCASPubMed Google Scholar
Weingartner H, Grafman J, Boutelle W, Kayne W, Martin PR (1983a): Forms of memory failure. Science221:380–382 ArticleCASPubMed Google Scholar
Weingartner H, Rudorfer MV, Buchsbaum MS, Linnoila M (1983b): Effects of serotonin on memory impairments produced by ethanol. Science221:472–473 ArticleCASPubMed Google Scholar
Weingartner H, Langer D, Grice J, Rapoport J (1982): Acquisition and retrieval of information in amphetamine-treated hyperactive children. Psychiatry Res6:21–29 ArticleCASPubMed Google Scholar